NCT06921785 · Interventional trial
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Overall registry status Recruiting
Phase 3
Conditions Hepatocellular Carcinoma
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County · Not yet recruiting
First posted
Registry updated
Added to the directory